# Rare complex recurrent cystic echinococcosis with multi-organ involvement after inadequate postoperative therapy: a case report

**Authors:** Yue Zhong, You Yuan, Yuting Zhang, Yu Zheng, Chunyan Chen

PMC · DOI: 10.3389/fmed.2025.1687259 · 2025-10-17

## TL;DR

A Tibetan man developed rare multi-organ cystic echinococcosis recurrence after inadequate treatment, requiring complex surgery and long-term monitoring.

## Contribution

Highlights the rarity and management challenges of multi-organ recurrent CE after inadequate postoperative care.

## Key findings

- Multi-organ CE recurrence occurred in a patient without standardized postoperative therapy or follow-up.
- Surgical removal of over 13 lesions was required, along with intensive care and albendazole therapy.
- No recurrence was observed at 1, 6, and 12 months post-surgery with continued monitoring.

## Abstract

Cystic echinococcosis (CE) is a globally prevalent zoonotic parasitic disease. Multi-organ recurrent CE is extremely rare, particularly in patients lacking standardized postoperative antiparasitic therapy or regular follow-up.

We report a 29-year-old Tibetan male who presented with progressive abdominal pain, distension, and a 15-kg weight loss over 6 months. He had undergone hepatic CE cystectomy 5 years earlier but did not receive regular albendazole therapy or follow-up. Imaging revealed multiple cystic lesions in the liver, spleen, greater omentum, and pelvic cavity. More than 13 lesions, including hepatic and diaphragmatic lesions, were excised during surgery, with concurrent management of vascular and urinary tract involvement. Intraoperative blood loss was approximately 2,800 mL, which required transfusion support and intensive care monitoring.

The patient stayed in the intensive care unit for 7 days and spent a total of 46 days in the hospital. After surgery, albendazole therapy was resumed. Follow-up evaluations at 1, 6, and 12 months showed no signs of recurrence, and long-term follow-up is still ongoing. Due to the potential for late recurrence of cystic echinococcosis, continued long-term monitoring is recommended.

Management of multi-organ recurrent CE requires standardized surgery, multidisciplinary collaboration, prolonged antiparasitic therapy, and strict follow-up. Ensuring patient adherence and providing health education are critical for improving long-term outcomes.

## Linked entities

- **Chemicals:** albendazole (PubChem CID 2082)
- **Diseases:** cystic echinococcosis (MONDO:0018408)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Diseases:** hepatic and diaphragmatic lesions (MESH:D006548), parasitic disease (MESH:D010272), weight loss (MESH:D015431), CE (MESH:D004443), abdominal pain (MESH:D015746), blood loss (MESH:D016063)
- **Chemicals:** albendazole (MESH:D015766)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12575342/full.md

---
Source: https://tomesphere.com/paper/PMC12575342